This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Default Category
-
U.S. Healthcare Reform: Reaction to the Patient Protection and Affordable Care Act of 2010
Daemmrich, Arthur A.Case HBS-711103-EEconomicsSupplement to "U.S. Healthcare Reform: International Perspectives," HBS No. 710-040, updating key events and disputes concerning the reform law, including the 2010 Congressional elections, legislative proposals, legal challenges, and responses by employers.Starting at €8.20
-
A Managerial Perspective on Clinical Trials
Daemmrich, Arthur A.Case HBS-709033-EEntrepreneurshipThis note describes the history and regulation of clinical trials, managerial challenges related to pharmaceutical product testing, and current debates regarding prescription drug safety. Since clinical testing takes between five and seven years, and consumes up to 70 percent of a drug's total development costs, pharmaceutical and biotechnology leaders need to understand clinical trial management. Likewise, with a growing variety of new product i...Starting at €8.20
-
Targanta Therapeutics: Hitting a Moving Target, Teaching Note
Daemmrich, Arthur A.Teaching Note HBS-710006-EEntrepreneurshipTeaching Note for [709002].Starting at €0.00
-
Arcadia Biosciences: Seeds of Change (Abridged)
Daemmrich, Arthur A.Case HBS-711050-EArcadia Biosciences is seeking to introduce genetically modified rice to China that will lower farmers' costs and generate environmental benefits through reduced greenhouse gas emissions. The case describes challenges facing this small agricultural biotechnology company, notably uneven enforcement of intellectual property in emerging market countries, and uncertainty regarding the provision and market value of carbon credits under international c...Starting at €8.20
-
Targanta Therapeutics: Hitting a Moving Target
Daemmrich, Arthur A.Case HBS-709002-EEntrepreneurshipThis case explores regulatory, product testing, and business strategy at Targanta Therapeutics, a biotech company preparing its first new drug application to the FDA. In October 2007, Mark Leuchtenberger, president and CEO of Targanta - which has just held a successful IPO - weighs options for the approximately ten month review period after the company submits to the Food and Drug Administration. The case reviews Targanta's origins and "de-riskin...Starting at €8.20
-
Arcadia Biosciences: Seeds of Change
Daemmrich, Arthur A.; Reinhardt, Forest L.; Shelman, MaryCase HBS-709019-EArcadia Biosciences is an entrepreneurial California agricultural biotech company seeking to earn carbon credits by modifying commodity crops for use in China and India. Eric Rey, Arcadia's CEO, faced a strategic inflection point in early September, 2008. The company had a plan to share carbon credits allocated by the United Nations Clean Development Mechanism Executive Board to China, for use of Arcadia's rice varieties, since they enabled farme...Starting at €8.20
-
U.S. Healthcare Reform: International Perspectives
Daemmrich, Arthur A.; Cameron, EliaCase HBS-710040-EEconomicsThe national economic implications of rising healthcare costs were poorly understood, even as the United States, Germany, and the United Kingdom instituted reforms in early 2010. Presenting opportunities for cross-national policy learning, this case describes the political economy of healthcare reform. In late March 2010, a major healthcare reform act was signed into law in the United States, expanding coverage and regulating insurers. However, i...Starting at €8.20
-
Arcadia Biosciences: Seeds of Change, Teaching Note
Daemmrich, Arthur A.; Reinhardt, Forest L.Teaching Note HBS-711042-ETeaching Note for 709019.Starting at €0.00
-
Targanta Therapeutics: Hitting a Moving Target (PPT)
Daemmrich, Arthur A.Case HBS-711056-EEntrepreneurshipStarting at €8.20
-
U.S. Healthcare Reform: International Perspectives, Teaching Note
Daemmrich, Arthur A.; Cameron, EliaTeaching Note HBS-711062-EEconomicsTeaching Note for #710-040 and 711-103.Starting at €0.00